Global Marketing Agreement On Vitamin K2 MK-7
Danisco and Kappa Bioscience announced to work in close collaboration on the emerging vitamin K2 MK-7 for…
Danisco and Kappa Bioscience announced to work in close collaboration on the emerging vitamin K2 MK-7 for the food industry in the areas of bone and cardiovascular health.
Kappa Bioscience is the first company to have developed a synthetic form of vitamin K2 MK-7, with the same full bioavailability and bioequivalence as natural vitamin K2 MK-7, in a proprietary process. With the addition of this new very pure vitamin K2 MK-7 in their ActivK™ range, Danisco will be able to bring further opportunities to food manufacturers to expand the use of this highly functional vitamin in even more cost-effective ways.
Creating new market opportunities
It is Danisco’s ambition and focus to establish vitamin K2 as a household name within food manufacturers. The umbrella brand ActivK™ currently includes the natural form of vitamin K2 MK-7, best known for its high presence in the traditional Japanese food Natto, which is proven suitable in a wide range of food & dietary applications.
EFSA stamp of approval
Vitamin K2, specifically the long chained menaquinones, are known to have crucial influence on bone and cardio functions, and recently, its importance was recognised by EFSA by granting a bone health claim for vitamin K.